← Back to Search

Procedure

standard awake extubation for Extubation (mDE Trial)

N/A
Recruiting
Research Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing laparoscopic surgery under general anesthesia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up just before extubation, and 1 minute and 5 minutes after extubation.
Awards & highlights

mDE Trial Summary

This trial aims to compare a modified deep extubation technique to the standard awake extubation method. The modified technique involves removing the breathing tube while the patient is still under anesthesia but with lower levels

Who is the study for?
This trial is for patients with physical status classifications ASA I-III who are undergoing laparoscopic surgery under general anesthesia. It's not specified who can't join, but typically those with higher risks or conditions that could interfere with the study might be excluded.Check my eligibility
What is being tested?
The study compares two ways of removing a breathing tube after surgery: standard awake extubation (AE) and modified deep extubation (mDE). mDE involves reducing anesthetic gas and using long-acting opioids to lessen airway reactions. The goal is to see if mDE speeds up recovery time in the operating room by at least 5 minutes.See study design
What are the potential side effects?
While specific side effects aren't listed, both AE and mDE may cause coughing or changes in blood pressure during waking from anesthesia. There's also a risk of airway complications which these methods aim to minimize.

mDE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am having surgery with small incisions under general anesthesia.

mDE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time from the end of the surgery to the moment the patient is ready to be discharged from pacu
This trial's timeline: 3 weeks for screening, Varies for treatment, and time from the end of the surgery to the moment the patient is ready to be discharged from pacu for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time from the end of the surgery to leaving the
Secondary outcome measures
BP
EtCO2
HR
+16 more

mDE Trial Design

2Treatment groups
Experimental Treatment
Group I: standard awake extubationExperimental Treatment1 Intervention
awake extubation (AE) is still considered the standard practice.
Group II: modified deep extubationExperimental Treatment1 Intervention
This modified deep extubation (mDE) occurs while the patient is still anaesthetized but at a lower dose of anaesthetic gas than previously described, and balanced with long acting opioids to attenuate the airway reaction.

Find a Location

Who is running the clinical trial?

Samuel Lunenfeld Research Institute, Mount Sinai HospitalLead Sponsor
127 Previous Clinical Trials
11,183 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total number of participants being selected for enrollment in this clinical trial?

"Indeed, information available on clinicaltrials.gov confirms the ongoing recruitment of subjects for this investigation. The study was first listed on April 3rd, 2024, and last modified on April 16th, 2024. Enrollment targets include recruiting a total of 60 participants across one designated site."

Answered by AI

Are there any available positions for participants in this research study?

"As per clinicaltrials.gov, this clinical investigation is actively seeking eligible participants. It was first listed on 4/3/2024 and most recently revised on 4/16/2024."

Answered by AI
~40 spots leftby Dec 2024